Poliomyelitis
Orthopedics · Topic 8
Source: NMC CBME Curriculum 2024 · Volume III · Orthopedics · Topic 8 · combined PDF page 448
Practice questions
- A person with residual weakness after acute anterior poliomyelitis has had decades of functional stability but now develops new weakness and fatigue. Which diagnosis best fits this pattern?
- A polio survivor develops gradual new functional decline after a prolonged stable period. Which statement best describes the usual onset of PPS?
- A polio survivor reports a marked increase in weakness soon after a period of immobilization. Which interpretation is best supported by the supplied PPS guideline?
- A patient with prior polio develops new motor deficits in muscles that were previously unaffected. In the supplied guideline, this finding is best regarded as:
- When distinguishing PPS from effects of aging in a person with old poliomyelitis sequelae, which feature does the supplied guideline identify as useful?
- A polio survivor has new weakness and functional decline. Which investigation is described as a valuable tool in evaluating such patients?
- A clinician evaluating a polio survivor with new neurological symptoms is uncertain whether the change represents PPS or another neurological disorder. What is an appropriate initial assessment approach?
- A polio survivor has new limb pain and reduced mobility. Which diagnostic consideration is specifically important because aging-related problems may be confused with PPS?
- Which course is most consistent with the described progression of PPS?
- A patient with suspected PPS asks whether a specific medicine can reverse the underlying syndrome. Which answer best reflects the supplied guideline?
- Which statement about pharmacological treatment of fatigue or muscle weakness in PPS is supported by the supplied guideline?
- Which approach is identified as essential both during initial assessment and in ongoing care of a person with PPS?
- A person with PPS has persistent pain. Which management principle is specifically supported by the supplied guideline?
- Which follow-up plan best matches the supplied guideline for a person with sequelae of acute anterior poliomyelitis and possible PPS?
- In long-term care of an older person with polio sequelae, which comorbidities deserve particular attention according to the supplied guideline?
- Which statement best describes vaccine-associated paralytic poliomyelitis (VAPP) in the supplied systematic review?
- Among the risk factors highlighted by the supplied systematic review of VAPP cases, which is prominent?
- A public-health discussion compares IPV with OPV with respect to vaccine-associated paralytic poliomyelitis. Which statement is supported by the supplied literature?
- Which routine childhood polio-vaccine schedule did the US ACIP recommend beginning January 1, 2000, in the cited historical recommendation?
- What was the principal reason the cited 2000 US ACIP recommendation moved to an all-IPV routine childhood schedule?
- According to the cited 1999 AAP recommendation, which strategy was advised for most children to reduce VAPP risk before the anticipated all-IPV recommendation?
- In the cited 1997 AAP recommendation, which regimens were considered acceptable for routine childhood polio vaccination, with four doses before school entry?
- Which benefit of OPV, in contrast to IPV, was cited in the historical ACIP discussion of vaccine policy?
- The 2014 Latin American Society of Pediatric Infectious Diseases declaration proposed which optimal IPV schedule for countries transitioning from OPV?
- During transition from OPV to IPV, which surveillance measures did the 2014 regional declaration recommend strengthening?
- Which additional immunization-system measure was included in the 2014 regional declaration alongside maintaining and improving vaccination coverage?
- A health authority planning IPV introduction asks which implementation issue was specifically included in the 2014 regional declaration. Which is the best answer?
- Which statement correctly characterizes the scope of the vaccine schedules cited in the supplied literature?